NEUROCRINE BIOSCIENCES
Live / Registered — Registered and renewed (as of 05 Sept 2023)
What this means for you
Registered since 25 Feb 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Feb 2023).
Record
- Serial number
- 75783702
- Registration number
- 2691306
- Mark type
- Stylized text
- Filed
- 24 Aug 1999
- Published for opposition
- 25 Apr 2000
- Registered
- 25 Feb 2003
- Next maintenance due
- 25 Feb 2023
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of [ cancer and ] neurological, endocrinological, and central nervous system disorders and diseases
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Sept 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 05 Sept 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Feb 2023 — TEAS SECTION 8 & 9 RECEIVED
- 25 Feb 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Aug 2019 — AMENDMENT UNDER SECTION 7 - PROCESSED